Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals, and related health care products worldwide. It operates in three segments: Pharmaceuticals, Nutritionals, and Other Health Care. The Pharmaceuticals segment offers cardiovascular products, including PLAVIX, PRAVACHOL, COUMADIN, and MONOPRIL; virology products comprising REYATAZ, SUSTIVA, ZERIT, and BARACLUDE; oncology products comprising ERBITUX, TAXOL, and SPRYCEL; affective and other psychiatric disorder products, such as ABILIFY and EMSAM; immunoscience products comprising ORENCIA; other infectious diseases products comprising CEFZIL;...